AAAAAA

   
Results: 1-25 | 26-49 |
Results: 26-49/49
Cost-effectiveness in the use of antibiotics
Authors: McNabb, J Quintiliani, R Nicolau, DP Grant, E Nightingale, CH
Citation: J. Mcnabb et al., Cost-effectiveness in the use of antibiotics, CURR CLIN I, 20, 2000, pp. 24-42
Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: Implications for breakpoint determinations
Authors: Nicolau, DP Onyeji, CO Zhong, MK Tessier, PR Banevicius, MA Nightingale, CH
Citation: Dp. Nicolau et al., Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: Implications for breakpoint determinations, ANTIM AG CH, 44(5), 2000, pp. 1291-1295
Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa
Authors: McNabb, J Quintiliani, R Nightingale, CH Nicolau, DP
Citation: J. Mcnabb et al., Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa, CHEMOTHERA, 46(6), 2000, pp. 383-389
Pharmacokinetics and pharmacodynamics of continuous and intermittent ceftazidime during the treatment of nosocomial pneumonia
Authors: Nicolau, DP McNabb, JC Lacy, MK Li, J Quintiliani, R Nightingale, CH
Citation: Dp. Nicolau et al., Pharmacokinetics and pharmacodynamics of continuous and intermittent ceftazidime during the treatment of nosocomial pneumonia, CLIN DRUG I, 18(2), 1999, pp. 133-139
Using pharmacodynamic and pharmacokinetic surrogate markers in clinical practice: Optimizing antimicrobial therapy in respiratory-tract infections
Authors: Nicolau, DP
Citation: Dp. Nicolau, Using pharmacodynamic and pharmacokinetic surrogate markers in clinical practice: Optimizing antimicrobial therapy in respiratory-tract infections, AM J HEAL S, 56, 1999, pp. S16-S20
Pharmacokinetics and pharmacoeconomic evaluation of ticarcillin-clavulanate administered as either continuous or intermittent infusion with once-daily gentamicin
Authors: Bui, KQ Ambrose, PG Grant, E Nightingale, CH Nicolau, DP Quintiliani, R
Citation: Kq. Bui et al., Pharmacokinetics and pharmacoeconomic evaluation of ticarcillin-clavulanate administered as either continuous or intermittent infusion with once-daily gentamicin, INF DIS C P, 8(9), 1999, pp. 449-455
Cost-effectiveness analysis of cefepime compared with ceftazidime in intensive care unit patients with hospital-acquired pneumonia
Authors: Ambrose, PG Richerson, MA Stanton, ME Bui, K Nicolau, DP Nightingale, CH Quintiliani, R
Citation: Pg. Ambrose et al., Cost-effectiveness analysis of cefepime compared with ceftazidime in intensive care unit patients with hospital-acquired pneumonia, INF DIS C P, 8(5), 1999, pp. 245-251
Pharmacokinetic and economic evaluation of piperacillin/tazobactam administered as either continuous or intermittent infusion with once-daily gentamicin
Authors: Richerson, MA Ambrose, PG Bui, KQ Grant, E Nicolau, DP Nightingale, CH Quintiliani, R
Citation: Ma. Richerson et al., Pharmacokinetic and economic evaluation of piperacillin/tazobactam administered as either continuous or intermittent infusion with once-daily gentamicin, INF DIS C P, 8(4), 1999, pp. 195-200
Pharmacokinetics of continuous and intermittent ceftazidime in intensive care unit patients with nosocomial pneumonia
Authors: Nicolau, DP Lacy, MK McNabb, JC Quintiliani, R Nightingale, CH
Citation: Dp. Nicolau et al., Pharmacokinetics of continuous and intermittent ceftazidime in intensive care unit patients with nosocomial pneumonia, INF DIS C P, 8(1), 1999, pp. 45-49
Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice
Authors: Onyeji, CO Bui, KQ Nicolau, DP Nightingale, CH Bow, L Quintiliani, R
Citation: Co. Onyeji et al., Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice, INT J ANT A, 12(4), 1999, pp. 301-309
Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia
Authors: Onyeji, CO Bui, KQ Owens, RC Nicolau, DP Quintiliani, R Nightingale, CH
Citation: Co. Onyeji et al., Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia, INT J ANT A, 12(2), 1999, pp. 107-114
Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis
Authors: Nicolau, DP Tessier, PR Nightingale, CH
Citation: Dp. Nicolau et al., Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis, INT J ANT A, 11(2), 1999, pp. 159-161
Interferon-gamma effects on activities of gentamicin and vancomycin against Enterococcus faecalis resistant to the drugs: an in vitro study with human neutrophils
Authors: Onyeji, CO Nicolau, DP Nightingale, CH Bow, L
Citation: Co. Onyeji et al., Interferon-gamma effects on activities of gentamicin and vancomycin against Enterococcus faecalis resistant to the drugs: an in vitro study with human neutrophils, INT J ANT A, 11(1), 1999, pp. 31-37
Population pharmacokinetics of continuous infusion ceftazidime
Authors: Frame, BC Facca, BF Nicolau, DP Triesenberg, SN
Citation: Bc. Frame et al., Population pharmacokinetics of continuous infusion ceftazidime, CLIN PHARMA, 37(4), 1999, pp. 343-350
Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model
Authors: Lacy, MK Nicolau, DP Banevicius, MA Nightingale, CH Quintiliani, R
Citation: Mk. Lacy et al., Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model, J ANTIMICRO, 44(4), 1999, pp. 477-481
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycinand azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis
Authors: Bui, KQ McNabb, J Li, CH Nightingale, CH Nicolau, DP
Citation: Kq. Bui et al., Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycinand azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis, ANTIM AG CH, 43(9), 1999, pp. 2302-2304
Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study
Authors: Keung, ACF Owens, RC Eller, MG Weir, SJ Nicolau, DP Nightingale, CH
Citation: Acf. Keung et al., Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study, ANTIM AG CH, 43(5), 1999, pp. 1230-1233
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillinagainst Streptococcus pneumoniae in an in vitro model of infection
Authors: Lacy, MK Lu, W Xu, XW Tessier, PR Nicolau, DP Quintiliani, R Nightingale, CH
Citation: Mk. Lacy et al., Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillinagainst Streptococcus pneumoniae in an in vitro model of infection, ANTIM AG CH, 43(3), 1999, pp. 672-677
Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS
Authors: Lacy, MK Nicolau, DP Nightingale, CH Geffken, A Teng, RL Vincent, J Quintiliani, R
Citation: Mk. Lacy et al., Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS, ANTIM AG CH, 43(12), 1999, pp. 3005-3007
Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model
Authors: Nicolau, DP Banevicius, MA Nightingale, CH Quintiliani, R
Citation: Dp. Nicolau et al., Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model, ANTIM AG CH, 43(12), 1999, pp. 3033-3035
Pharmacokinetics of ticlopidine in the rabbit
Authors: Onyeji, CO Tessier, PR Nightingale, CH Vallee, F Nicolau, DP
Citation: Co. Onyeji et al., Pharmacokinetics of ticlopidine in the rabbit, J PHARM PHA, 51(4), 1999, pp. 393-396
Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosain an in vitro infection model
Authors: Tessier, PR Nicolau, DP Onyeji, CO Nightingale, CH
Citation: Pr. Tessier et al., Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosain an in vitro infection model, CHEMOTHERA, 45(4), 1999, pp. 284-295
Continuous vs. intermittent infusion of cefuroxime for the treatment of community-acquired pneumonia
Authors: Ambrose, PG Quintiliani, R Nightingale, CH Nicolau, DP
Citation: Pg. Ambrose et al., Continuous vs. intermittent infusion of cefuroxime for the treatment of community-acquired pneumonia, INF DIS C P, 7(9), 1998, pp. 463-470
Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae
Authors: Lacy, MK Owens, RC Xu, XW Nicolau, DP Quintiliani, R Nightingale, CH
Citation: Mk. Lacy et al., Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae, INT J ANT A, 10(4), 1998, pp. 279-283
Risultati: 1-25 | 26-49 |